ergotamine has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Combs, MD; Edwards, SH; Kessell, AE; Narayan, EJ; Piltz, J; Quinn, JC; Raidal, SR; Ramsay, J; Scherpenhuizen, JM | 1 |
| Anguiano-Robledo, L; Lacivita, E; Leopoldo, M; López-Sánchez, P; Sánchez-Maldonado, C; Terrón, JA | 1 |
| Arulmani, U; Centurión, D; Sánchez-Lopez, A; Saxena, PR; Vázquez, E; Villalón, CM | 1 |
| Nakamura, M | 1 |
| Filinova, ZS | 1 |
| de Vlaam-Schluter, GM; Saxena, PR | 1 |
| Besznyák, I; Nemes, A; Rényi-Vámos, F; Sebestény, M | 1 |
2 review(s) available for ergotamine and Disease Models, Animal
| Article | Year |
|---|---|
[Coronary artery spasm: definition, clinical characteristics, prognosis and experimental animal models].
Topics: Aged; Alcoholic Beverages; Angina Pectoris, Variant; Animals; Coronary Vasospasm; Disease Models, Animal; Dogs; Ergotamine; Humans; Male; Prognosis; Swine; Syncope | 1987 |
Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Bradykinin; Carotid Arteries; Cerebrovascular Circulation; Clonidine; Disease Models, Animal; Dogs; Ergotamine; Histamine H1 Antagonists; Methysergide; Migraine Disorders; Norepinephrine; Serotonin Antagonists; Vascular Resistance; Vasoconstrictor Agents | 1974 |
5 other study(ies) available for ergotamine and Disease Models, Animal
| Article | Year |
|---|---|
Development of a model for investigation of perennial ryegrass toxicosis in sheep.
Topics: Analysis of Variance; Animals; Autopsy; Disease Models, Animal; Electromyography; Ergotamine; Feces; Gait; Indole Alkaloids; Lolium; Male; Mycotoxins; New South Wales; Random Allocation; Sheep; Sheep Diseases | 2018 |
GR-127935-sensitive mechanism mediating hypotension in anesthetized rats: are 5-HT5B receptors involved?
Topics: Animals; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergotamine; Hypotension; Oxadiazoles; Piperazines; Piperidones; Rats; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds | 2015 |
Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
Topics: Animals; Autonomic Fibers, Preganglionic; Blood Pressure; Decerebrate State; Desipramine; Disease Models, Animal; Drug Therapy, Combination; Electric Stimulation; Ergotamine; Infusions, Intravenous; Injections, Intravenous; Male; Oxadiazoles; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sympathetic Nervous System; Tachycardia | 2003 |
Effect of dihydroergotamine on partial functions of the kidneys and water and salt metabolism in dogs with experimental hypertension.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Diuresis; Dogs; Ergotamine; Glomerular Filtration Rate; Hypertension; Kidney; Natriuresis; Pituitary Hormones, Posterior; Sodium; Vasomotor System; Water-Electrolyte Balance | 1974 |
Hyperbaric oxygenation as a therapeutic method in experimental subacute and chronic peripheral circulatory disturbances.
Topics: Animals; Disease Models, Animal; Ergotamine; Ethanolamines; Gangrene; Hyperbaric Oxygenation; Ischemia; Male; Nicotinic Acids; Papaverine; Parasympatholytics; Rats; Regional Blood Flow; Vascular Diseases; Vasodilator Agents | 1969 |